INBS INTELLIGENT BIO SOLUTIONS INC.

Nasdaq gbs.inc


$ 0.71 $ -0.06 (-8.3 %)    

Thursday, 13-Nov-2025 15:57:26 EST
QQQ $ 608.60 $ -9.26 (-1.5 %)
DIA $ 475.45 $ -6.59 (-1.37 %)
SPY $ 672.58 $ -8.41 (-1.24 %)
TLT $ 89.42 $ -0.42 (-0.46 %)
GLD $ 383.58 $ -4.31 (-1.11 %)
$ 0.793
$ 0.78
$ 0.68 x 5
$ 0.82 x 500
$ 0.71 - $ 0.77
$ 0.73 - $ 2.75
244,474
na
7.5M
$ 2.10
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-12-2025 09-30-2025 10-Q
2 08-15-2025 06-30-2025 10-K
3 05-13-2025 03-31-2025 10-Q
4 02-13-2025 12-31-2024 10-Q
5 11-07-2024 09-30-2024 10-Q
6 09-18-2024 06-30-2024 10-K
7 05-08-2024 03-31-2024 10-Q
8 02-09-2024 12-31-2023 10-Q
9 11-08-2023 09-30-2023 10-Q
10 08-23-2023 06-30-2023 10-K
11 05-11-2023 03-31-2023 10-Q
12 02-14-2023 12-31-2022 10-Q
13 11-14-2022 09-30-2022 10-Q
14 09-22-2022 06-30-2022 10-K
15 05-16-2022 03-31-2022 10-Q
16 02-10-2022 12-31-2021 10-Q
17 11-12-2021 09-30-2021 10-Q
18 09-16-2021 06-30-2021 10-K
19 05-13-2021 03-31-2021 10-Q
20 02-12-2021 12-31-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 intelligent-bio-solutions-q1-eps-035-up-from-070-yoy-sales-1112m-up-from-872287k-yoy

Intelligent Bio Solutions (NASDAQ:INBS) reported quarterly losses of $(0.35) per share. This is a 50 percent increase over loss...

 intelligent-bio-solutions-expects-to-report-q1-revenue-growth-of-32-sequentially-and-28-yoy

Company Achieves Third Consecutive Quarter of Revenue GrowthRevenue Increase of Approximately 32% Sequentially and 28% Year-Ove...

 intelligent-bio-solutions-initiates-clinical-studies-for-fingerprint-drug-screening-system-targets-fda-510k-clearance-in-h2-2026-for-codeine-detection

The Company is initiating clinical studies to further validate Intelligent Fingerprinting Drug Screening SystemINBS anticipates...

 intelligent-bio-solutions-receives-fda-feedback-preparing-to-resubmit-510k-for-intelligent-fingerprinting-drug-screening-system

Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering...

 intelligent-bio-solutions-posts-60-yoy-growth-in-july-cartridge-sales-surpassing-12500-units

Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering...

 intelligent-bio-solutions-q4-eps-036-sales-843884k-up-from-727824k-yoy

Intelligent Bio Solutions (NASDAQ:INBS) reported quarterly losses of $(0.36) per share. The company reported $843.884 thousand...

 intelligent-bio-solutions-secures-major-contract-to-deploy-drug-screening-system-across-londons-public-transport-network

Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering...

 intelligent-bio-solutions-study-confirms-codeine-detection-in-fingerprint-sweat-validating-non-invasive-drug-screening-system

Data shows excretion of codeine in fingerprint sweatINBS' System is viable option for non-invasive diagnostic testingNEW YO...

 intelligent-bio-solutions-sees-accelerated-nordic-adoption-of-fingerprint-drug-testing-through-spjotgard-partnership

Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering...

 intelligent-bio-solutions-integrates-latin-american-spanish-into-intelligent-fingerprinting-drug-screening-system

Company expands Intelligent Fingerprinting Drug Screening System multilingual capabilities to meet growing demand across Latin ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION